Your browser doesn't support javascript.
loading
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - YES.
Freedman, Mark; Atkins, Harold L.
Affiliation
  • Freedman M; University of Ottawa-Neuroscience, Ottawa, ON, Canada mfreedman@toh.ca.
  • Atkins HL; Regenerative Medicine, Ottawa Hospital Research Institute-Medicine, Ottawa, ON, Canada.
Mult Scler ; 22(10): 1258-9, 2016 09.
Article in En | MEDLINE | ID: mdl-27444560
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Hematopoietic Stem Cell Transplantation / Multiple Sclerosis Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2016 Document type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Hematopoietic Stem Cell Transplantation / Multiple Sclerosis Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2016 Document type: Article Affiliation country: Canada